Expressing support for the recognition of "Hidradenitis Suppurativa Awareness Week".

Designating the first week of June as "Hidradenitis Suppurativa Awareness Week" would spotlight a chronic inflammatory skin disease and push for earlier diagnosis, better access to care, and more research. HS affects about 3.3 million Americans, causes painful nodules, tunnels under the skin, scarring, and deep physical and emotional distress, 75% of people with HS are misdiagnosed or not diagnosed until after age 25, HS has the second-highest completed suicide rate among dermatologic diseases, and three biologic therapies were FDA approved as of June 1, 2025.